Selecta Biosciences

Selecta Biosciences

World Rank (Jan-05-2024)
19,733
Market Cap (Jan-05-2024)
0.140 Billion USD
World Rank (Jul-30-2023)
19,120
Market Cap (Jul-30-2023)
0.164 Billion USD
World Rank (Jan-07-2022)
15,851
Market Cap (Jan-07-2022)
0.339 Billion USD
World Rank (Jan-01-2021)
13,303
Market Cap (Jan-01-2021)
0.325 Billion USD
Headquarters Country
USA
Employee Count
58
Employee Count as of Date
As on 2021
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
17 Million USD
Annual Net Income in USD
-69 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Balance Sheet for Period Ending
Dec-2020 ending year
Business Sector
Healthcare
Biotechnology
Company Website
SELECTA BIOSCIENCES
Yahoo
Yahoo @ Frankfurt
Company Profile

Selecta Biosciences is a Biopharmaceutical and Gene Therapy company wholly owned, proprietary pipeline and work with partners with the goal of addressing immunogenicity to create life changing therapies for patients and their families. The company annual revenue is 27.6 million USD and 39 employees as on 2019. The headquarters is in USA.

Founded Year
2007
IPO Year
2016
Stock Exchange
Nasdaq
Frankfurt

Share